Yixintang Pharmaceutical Group Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: CNE100001WJ8
CNY
13.03
-0.11 (-0.84%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
17,930.52
17,301.38
17,395.49
14,547.99
12,624.09
10,426.86
9,104.85
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
17,930.52
17,301.38
17,395.49
14,547.99
12,624.09
10,426.86
9,104.85
Raw Material Cost
12,387.20
11,750.35
11,411.93
9,286.69
8,200.48
6,495.78
5,527.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
150.89
139.79
151.15
140.02
27.98
39.78
53.71
Selling and Distribution Expenses
5,066.04
4,600.71
4,506.83
4,014.24
3,482.97
3,191.63
2,790.72
Other Expenses
-14.12
-12.96
-14.24
-13.46
-2.71
-3.95
-5.36
Total Expenditure (Excl Depreciation)
17,462.96
16,361.26
15,927.50
13,306.31
11,684.29
9,687.65
8,318.33
Operating Profit (PBDIT) excl Other Income
467.59999999999997
940.1
1468
1241.7
939.8000000000001
739.2
786.5
Other Income
21.29
36.17
83.42
74.33
99.02
56.17
48.54
Operating Profit (PBDIT)
1,838.55
2,202.12
2,557.95
2,465.15
1,237.40
1,062.82
948.59
Interest
150.89
139.79
151.15
140.02
27.98
39.78
53.71
Exceptional Items
-29.27
-20.01
-18.21
-16.74
-13.19
-26.59
-21.00
Gross Profit (PBDT)
5,543.32
5,551.03
5,983.56
5,261.31
4,423.62
3,931.08
3,577.38
Depreciation
1,440.14
1,332.41
1,152.66
1,208.42
239.43
246.91
180.69
Profit Before Tax
218.26
709.90
1,235.92
1,099.98
956.80
749.54
693.18
Tax
97.02
142.15
222.00
179.32
167.73
145.73
171.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
114.14
549.44
1,010.00
921.58
789.96
603.92
521.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
114.14
549.44
1,010.00
921.58
789.96
603.92
521.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.85
10.97
2.98
-4.38
-0.79
-0.60
-1.30
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
110.29
560.41
1,012.98
917.21
789.17
603.32
519.77
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,491.01
7,745.98
7,426.15
6,577.75
5,765.41
4,594.92
4,050.99
Earnings per share (EPS)
0.19
0.92
1.7
1.56
1.38
1.06
0.92
Diluted Earnings per share
0.19
0.92
1.7
1.56
1.38
1.06
0.92
Operating Profit Margin (Excl OI)
2.1%
4.82%
7.6%
8.13%
7.12%
7.29%
7.9%
Gross Profit Margin
9.25%
11.8%
13.73%
15.87%
9.48%
9.56%
9.6%
PAT Margin
0.64%
3.18%
5.81%
6.33%
6.26%
5.79%
5.72%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 3.64% vs -0.54% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -80.32% vs -44.68% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -16.09% vs -12.47% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 7.94% vs -7.48% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Yixintang Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
17,930.52
0
17,930.52
Other Operating Income
0.00
0.00
0.00
Total Operating income
17,930.52
0
17,930.52
Raw Material Cost
12,387.20
0
12,387.20
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
150.89
0
150.89
Selling and Distribution Expenses
5,066.04
0
5,066.04
Other Expenses
-14.12
0.00
-14.12
Total Expenditure (Excl Depreciation)
17,462.96
0
17,462.96
Operating Profit (PBDIT) excl Other Income
467.56
0.00
467.56
Other Income
21.29
0
21.29
Operating Profit (PBDIT)
1,838.55
0
1,838.55
Interest
150.89
0
150.89
Exceptional Items
-29.27
0
-29.27
Gross Profit (PBDT)
5,543.32
0
5,543.32
Depreciation
1,440.14
0
1,440.14
Profit Before Tax
218.26
0
218.26
Tax
97.02
0
97.02
Provisions and contingencies
0
0
0.00
Profit After Tax
114.14
0
114.14
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
114.14
0
114.14
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.85
0
-3.85
Other related items
0.00
0.00
0.00
Consolidated Net Profit
110.29
0
110.29
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,491.01
0
7,491.01
Earnings per share (EPS)
0.19
0
0.19
Diluted Earnings per share
0.19
0
0.19
Operating Profit Margin (Excl OI)
2.10%
0%
0.00
2.10%
Gross Profit Margin
9.25%
0%
0.00
9.25%
PAT Margin
0.64%
0%
0.00
0.64%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,793.05 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 3.64% vs -0.54% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 11.03 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -80.32% vs -44.68% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 181.73 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -16.09% vs -12.47% in Dec 2023

Annual - Interest
Interest 15.09 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 7.94% vs -7.48% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.10%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023